Posts by droussel
Presentation at the ISSWSH 2025
Pelvipharm and Otrera Medical Inc present new findings on the Relaxant Effects of Cannabidiol in Rats at the ISSWSH Meeting in Atlanta, USA, February 27 – March 2, 2025.
Harin Padma-Nathan will present a digital poster during the poster session entitled “Clinical Trials / Novel Drugs, Methods and Technologies / Basic Science” to present new findings on the Relaxant Effects of Cannabidiol in Rats.
“Relaxant Effects of Cannabidiol on Electrical Field Stimulation-induced Smooth Muscle Contractility of Vaginal Strips from Normal and Oophorectomized Rats”
Padma-Nathan, H; Frid, M; Gorny, D; Assaly, R; Behr-Roussel, D.
Please reach out if you want to discuss our results on the relaxant effect of cannabidiol in rats and potential applications for you.
Happy New Year from Pelvipharm!
As we step into 2025, the Pelvipharm SAS team extends its heartfelt gratitude to all our collaborators, partners, and clients. Thank you for making 2024 an exceptional year! Your trust and support have been the cornerstone of our achievements.
Looking forward, we are thrilled to continue this journey together. Building on last year’s successes, we aim even higher in 2025 with unwavering dedication to innovation and excellence. Let’s make this year remarkable!
Presentation at the ICS 2024
Presentation at the Congress of the ICS 2024 (International Continence Society) in Madrid, Spain, 23-25 October, 2024 reports new Viral Vector HSV1 Efficacy Studies in urology.
Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm:
RATELADE J, EPSTEIN A, DENYS P, GIULIANO F, HAAG-MOLKENTELLER C, SALOT S.
EG110A, a novel non-replicative HSV1-derived vector expressing the light chain of botulinum toxin F, shows dose-dependent efficacy in an acute intravesical capsaicin rat model.
Continence (Oct 2024)
ICS 2024 – Best in Category Prize: Research Methods / Techniques.
ASSALY R., COMPAGNIE S., ALLIMONNIER L., BRACCONI M., GIULIANO F. AND BEHR-ROUSSEL D.
Establishment and validation of a rodent model of endometriosis to evaluate the effect of new therapeutic strategies.
J Gynecol Res Obstet – 2022 Oct : 8(3):036-042
F. GIULIANO, D. GORNY, M. RAZANAKOLONA, D. BEHR-ROUSSEL, R. ASSALY, C. GAUFFIN
LIB-01, a novel promising oral drug under development for the treatment of erectile dysfunction (ED) – a summary of nonclinical studies.
ESSM 2024 (Bari, Italy, Oral presentation).
The Journal of Sexual Medicine, Volume 19, Issue 11, Supplement 4, November 2024, Page S3.
GORNY D., RAZANAKOLONA M., GAUFFIN C., BEHR-ROUSSEL D., GIULIANO F., ASSALY R.
The pro-erectile facilitator effect of LIB-01 in anesthetized Wistar rats is likely mainly mediated via an NO/cGMP-independent pathway
ESSM 2023 (Rotterdam, Oral presentation)